
- July 2019 Gastrointestinal Issues
- Volume 85
- Issue 7
Expanding the Role of Pharmacists in the Administration of Long-Acting Injectable Antipsychotic Medications
Continuing education for administration of long-acting injectable antipsychotic medications.
Faculty
Misty L. Gonzalez, PharmD, BCPP, Clinical Associate Professor, Southern Illinois University, Edwardsville School of Pharmacy, Edwardsville, Illinois
Danielle Moses, PharmD, BCPP, Psychiatric Pharmacist, SSM Health DePaul Hospital, St. Louis, Missouri
Educational Objectives
At the completion of this activity, the participant will be able to:
- Examine nonadherence data among patients with mental illness
- Identify legislative changes that have expanded the role of pharmacists in providing long-acting injectable antipsychotic (LAIA) medications to patients
- Explore FDA-approved formulations and administration of LAIAs
- Demonstrate the appropriate administration of LAI therapies in practice
Target Audience: Pharmacists
Activity Type: Application
Release Date: July 19, 2019
Expiration Date: July 19, 2020
Estimated Time to Complete Activity: 2.5 hours
Fee: This lesson is offered for free at
Articles in this issue
about 7 years ago
Pharmacy Law: Pharmacist and Assistant Are Indicted on Chargesabout 7 years ago
Reporting and Second-Order Problem Solving Are Criticalabout 7 years ago
Norovirus Presents Patient Care Obstaclesabout 7 years ago
Highlights From the Cardinal Health Retail Business Conference 2019about 7 years ago
OTC Case Studies: Stomach Issuesabout 7 years ago
Counsel Patients About the Symptoms of Celiac Diseaseabout 7 years ago
Consider Interactions With Analgesics When Treating Neuropathiesabout 7 years ago
Case Studies (July 2019)about 7 years ago
Combating Diversion in Health Care Facilities Presents Challenges





































































































